# Comparison of the ECG Effects Related to Pharmacokinetic Profile of Chloroquine and Piperaquine

> **NCT02192944** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Chloroquine
- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT02192944
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192944, "Comparison of the ECG Effects Related to Pharmacokinetic Profile of Chloroquine and Piperaquine". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02192944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*